Cellestia Biotech

Cellestia Biotech

Cellestia Biotech

Cellestia is a bio-pharmaceutical company with strategic focus on anti-cancer drugs modulating the NOTCH signaling pathway.
Type
B2b
Founded
2014
Raised
$28.4M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$20,395,400
Venture capital (Series B) - 2019
Partners Investment PPF Group FC Capital
$8,000,000
Seed fund - 2017
Go Beyond Investing PPF Group
Team Size
1–10
Employees
$20,395,400 Venture capital (Series B)
FinSMEs

Cellestia Biotech Closes CHF20M Series B Financing

$8,000,000 Seed fund
Marketwire

Cellestia Biotech AG: Cellestia Biotech raises CHF 8M seed financing